King Pharma Names Markison COO
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Bristol-Myers Squibb President-Oncology & Virology Brian Markison is joining King Pharmaceutical in the newly created position of chief operating officer
You may also be interested in...
King Names Markison President & CEO
Brian Markison was also elected to the company's board of directors. He joined King as chief operating officer in March, and was named acting president and CEO in May.
King Names Markison President & CEO
Brian Markison was also elected to the company's board of directors. He joined King as chief operating officer in March, and was named acting president and CEO in May.
King Names Markison Acting CEO; President Macione Steps Down
Chief Operating Officer Brian Markison will assume the duties of CEO Jefferson Gregory and President Kyle Macione, who are both leaving the company. King taps former pharma industry exec Ted Wood as chairman.